- IBDEI2QD ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,43540,1,3,0)
- ;;=3^Psychomtr Dfct s/p Unsp Cebrvsc Dis
- ;;^UTILITY(U,$J,358.3,43540,1,4,0)
- ;;=4^I69.913
- ;;^UTILITY(U,$J,358.3,43540,2)
- ;;=^5138663
- ;;^UTILITY(U,$J,358.3,43541,0)
- ;;=I69.914^^160^2124^31
- ;;^UTILITY(U,$J,358.3,43541,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,43541,1,3,0)
- ;;=3^Front Lobe/Exec Fx Dfct s/p Unsp Crbrovs Dis
- ;;^UTILITY(U,$J,358.3,43541,1,4,0)
- ;;=4^I69.914
- ;;^UTILITY(U,$J,358.3,43541,2)
- ;;=^5138664
- ;;^UTILITY(U,$J,358.3,43542,0)
- ;;=I69.915^^160^2124^15
- ;;^UTILITY(U,$J,358.3,43542,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,43542,1,3,0)
- ;;=3^Cog Social/Emot Dfct s/p Crbrvsc Dis
- ;;^UTILITY(U,$J,358.3,43542,1,4,0)
- ;;=4^I69.915
- ;;^UTILITY(U,$J,358.3,43542,2)
- ;;=^5138665
- ;;^UTILITY(U,$J,358.3,43543,0)
- ;;=I69.918^^160^2124^48
- ;;^UTILITY(U,$J,358.3,43543,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,43543,1,3,0)
- ;;=3^Sym/Sgns Cog Fxn Dfct s/p Unsp Crbrvsc Dis,Oth
- ;;^UTILITY(U,$J,358.3,43543,1,4,0)
- ;;=4^I69.918
- ;;^UTILITY(U,$J,358.3,43543,2)
- ;;=^5138666
- ;;^UTILITY(U,$J,358.3,43544,0)
- ;;=I69.919^^160^2124^49
- ;;^UTILITY(U,$J,358.3,43544,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,43544,1,3,0)
- ;;=3^Sym/Sgns Cog Fxn Dfct s/p Unsp Crbrvsc Dis,Unsp
- ;;^UTILITY(U,$J,358.3,43544,1,4,0)
- ;;=4^I69.919
- ;;^UTILITY(U,$J,358.3,43544,2)
- ;;=^5138667
- ;;^UTILITY(U,$J,358.3,43545,0)
- ;;=I69.993^^160^2124^13
- ;;^UTILITY(U,$J,358.3,43545,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,43545,1,3,0)
- ;;=3^Ataxia following unspec Cerebrovasc Disease
- ;;^UTILITY(U,$J,358.3,43545,1,4,0)
- ;;=4^I69.993
- ;;^UTILITY(U,$J,358.3,43545,2)
- ;;=^5007571
- ;;^UTILITY(U,$J,358.3,43546,0)
- ;;=I69.998^^160^2124^16
- ;;^UTILITY(U,$J,358.3,43546,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,43546,1,3,0)
- ;;=3^Disturbance of Vision
- ;;^UTILITY(U,$J,358.3,43546,1,4,0)
- ;;=4^I69.998
- ;;^UTILITY(U,$J,358.3,43546,2)
- ;;=^5007572
- ;;^UTILITY(U,$J,358.3,43547,0)
- ;;=I69.992^^160^2124^29
- ;;^UTILITY(U,$J,358.3,43547,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,43547,1,3,0)
- ;;=3^Facial Weakness s/p Unspec Cerebrov Dis
- ;;^UTILITY(U,$J,358.3,43547,1,4,0)
- ;;=4^I69.992
- ;;^UTILITY(U,$J,358.3,43547,2)
- ;;=^5007570
- ;;^UTILITY(U,$J,358.3,43548,0)
- ;;=I69.923^^160^2124^30
- ;;^UTILITY(U,$J,358.3,43548,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,43548,1,3,0)
- ;;=3^Fluency Disorder s/p Unspec Cerebrov Dis
- ;;^UTILITY(U,$J,358.3,43548,1,4,0)
- ;;=4^I69.923
- ;;^UTILITY(U,$J,358.3,43548,2)
- ;;=^5007556
- ;;^UTILITY(U,$J,358.3,43549,0)
- ;;=I69.951^^160^2124^34
- ;;^UTILITY(U,$J,358.3,43549,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,43549,1,3,0)
- ;;=3^Hemiplegia Affecting Rt Dominant Side
- ;;^UTILITY(U,$J,358.3,43549,1,4,0)
- ;;=4^I69.951
- ;;^UTILITY(U,$J,358.3,43549,2)
- ;;=^5007561
- ;;^UTILITY(U,$J,358.3,43550,0)
- ;;=I69.952^^160^2124^32
- ;;^UTILITY(U,$J,358.3,43550,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,43550,1,3,0)
- ;;=3^Hemiplegia Affecting Lt Dominant Side
- ;;^UTILITY(U,$J,358.3,43550,1,4,0)
- ;;=4^I69.952
- ;;^UTILITY(U,$J,358.3,43550,2)
- ;;=^5133586
- ;;^UTILITY(U,$J,358.3,43551,0)
- ;;=I69.953^^160^2124^35
- ;;^UTILITY(U,$J,358.3,43551,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,43551,1,3,0)
- ;;=3^Hemiplegia Affecting Rt Non-Dominant Side
- ;;^UTILITY(U,$J,358.3,43551,1,4,0)
- ;;=4^I69.953
- ;;^UTILITY(U,$J,358.3,43551,2)
- ;;=^5007562
- ;;^UTILITY(U,$J,358.3,43552,0)
- ;;=I69.954^^160^2124^33
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2QD 3752 printed Feb 19, 2025@00:00:13 Page 2
- IBDEI2QD ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,43540,1,3,0)
- +2 ;;=3^Psychomtr Dfct s/p Unsp Cebrvsc Dis
- +3 ;;^UTILITY(U,$J,358.3,43540,1,4,0)
- +4 ;;=4^I69.913
- +5 ;;^UTILITY(U,$J,358.3,43540,2)
- +6 ;;=^5138663
- +7 ;;^UTILITY(U,$J,358.3,43541,0)
- +8 ;;=I69.914^^160^2124^31
- +9 ;;^UTILITY(U,$J,358.3,43541,1,0)
- +10 ;;=^358.31IA^4^2
- +11 ;;^UTILITY(U,$J,358.3,43541,1,3,0)
- +12 ;;=3^Front Lobe/Exec Fx Dfct s/p Unsp Crbrovs Dis
- +13 ;;^UTILITY(U,$J,358.3,43541,1,4,0)
- +14 ;;=4^I69.914
- +15 ;;^UTILITY(U,$J,358.3,43541,2)
- +16 ;;=^5138664
- +17 ;;^UTILITY(U,$J,358.3,43542,0)
- +18 ;;=I69.915^^160^2124^15
- +19 ;;^UTILITY(U,$J,358.3,43542,1,0)
- +20 ;;=^358.31IA^4^2
- +21 ;;^UTILITY(U,$J,358.3,43542,1,3,0)
- +22 ;;=3^Cog Social/Emot Dfct s/p Crbrvsc Dis
- +23 ;;^UTILITY(U,$J,358.3,43542,1,4,0)
- +24 ;;=4^I69.915
- +25 ;;^UTILITY(U,$J,358.3,43542,2)
- +26 ;;=^5138665
- +27 ;;^UTILITY(U,$J,358.3,43543,0)
- +28 ;;=I69.918^^160^2124^48
- +29 ;;^UTILITY(U,$J,358.3,43543,1,0)
- +30 ;;=^358.31IA^4^2
- +31 ;;^UTILITY(U,$J,358.3,43543,1,3,0)
- +32 ;;=3^Sym/Sgns Cog Fxn Dfct s/p Unsp Crbrvsc Dis,Oth
- +33 ;;^UTILITY(U,$J,358.3,43543,1,4,0)
- +34 ;;=4^I69.918
- +35 ;;^UTILITY(U,$J,358.3,43543,2)
- +36 ;;=^5138666
- +37 ;;^UTILITY(U,$J,358.3,43544,0)
- +38 ;;=I69.919^^160^2124^49
- +39 ;;^UTILITY(U,$J,358.3,43544,1,0)
- +40 ;;=^358.31IA^4^2
- +41 ;;^UTILITY(U,$J,358.3,43544,1,3,0)
- +42 ;;=3^Sym/Sgns Cog Fxn Dfct s/p Unsp Crbrvsc Dis,Unsp
- +43 ;;^UTILITY(U,$J,358.3,43544,1,4,0)
- +44 ;;=4^I69.919
- +45 ;;^UTILITY(U,$J,358.3,43544,2)
- +46 ;;=^5138667
- +47 ;;^UTILITY(U,$J,358.3,43545,0)
- +48 ;;=I69.993^^160^2124^13
- +49 ;;^UTILITY(U,$J,358.3,43545,1,0)
- +50 ;;=^358.31IA^4^2
- +51 ;;^UTILITY(U,$J,358.3,43545,1,3,0)
- +52 ;;=3^Ataxia following unspec Cerebrovasc Disease
- +53 ;;^UTILITY(U,$J,358.3,43545,1,4,0)
- +54 ;;=4^I69.993
- +55 ;;^UTILITY(U,$J,358.3,43545,2)
- +56 ;;=^5007571
- +57 ;;^UTILITY(U,$J,358.3,43546,0)
- +58 ;;=I69.998^^160^2124^16
- +59 ;;^UTILITY(U,$J,358.3,43546,1,0)
- +60 ;;=^358.31IA^4^2
- +61 ;;^UTILITY(U,$J,358.3,43546,1,3,0)
- +62 ;;=3^Disturbance of Vision
- +63 ;;^UTILITY(U,$J,358.3,43546,1,4,0)
- +64 ;;=4^I69.998
- +65 ;;^UTILITY(U,$J,358.3,43546,2)
- +66 ;;=^5007572
- +67 ;;^UTILITY(U,$J,358.3,43547,0)
- +68 ;;=I69.992^^160^2124^29
- +69 ;;^UTILITY(U,$J,358.3,43547,1,0)
- +70 ;;=^358.31IA^4^2
- +71 ;;^UTILITY(U,$J,358.3,43547,1,3,0)
- +72 ;;=3^Facial Weakness s/p Unspec Cerebrov Dis
- +73 ;;^UTILITY(U,$J,358.3,43547,1,4,0)
- +74 ;;=4^I69.992
- +75 ;;^UTILITY(U,$J,358.3,43547,2)
- +76 ;;=^5007570
- +77 ;;^UTILITY(U,$J,358.3,43548,0)
- +78 ;;=I69.923^^160^2124^30
- +79 ;;^UTILITY(U,$J,358.3,43548,1,0)
- +80 ;;=^358.31IA^4^2
- +81 ;;^UTILITY(U,$J,358.3,43548,1,3,0)
- +82 ;;=3^Fluency Disorder s/p Unspec Cerebrov Dis
- +83 ;;^UTILITY(U,$J,358.3,43548,1,4,0)
- +84 ;;=4^I69.923
- +85 ;;^UTILITY(U,$J,358.3,43548,2)
- +86 ;;=^5007556
- +87 ;;^UTILITY(U,$J,358.3,43549,0)
- +88 ;;=I69.951^^160^2124^34
- +89 ;;^UTILITY(U,$J,358.3,43549,1,0)
- +90 ;;=^358.31IA^4^2
- +91 ;;^UTILITY(U,$J,358.3,43549,1,3,0)
- +92 ;;=3^Hemiplegia Affecting Rt Dominant Side
- +93 ;;^UTILITY(U,$J,358.3,43549,1,4,0)
- +94 ;;=4^I69.951
- +95 ;;^UTILITY(U,$J,358.3,43549,2)
- +96 ;;=^5007561
- +97 ;;^UTILITY(U,$J,358.3,43550,0)
- +98 ;;=I69.952^^160^2124^32
- +99 ;;^UTILITY(U,$J,358.3,43550,1,0)
- +100 ;;=^358.31IA^4^2
- +101 ;;^UTILITY(U,$J,358.3,43550,1,3,0)
- +102 ;;=3^Hemiplegia Affecting Lt Dominant Side
- +103 ;;^UTILITY(U,$J,358.3,43550,1,4,0)
- +104 ;;=4^I69.952
- +105 ;;^UTILITY(U,$J,358.3,43550,2)
- +106 ;;=^5133586
- +107 ;;^UTILITY(U,$J,358.3,43551,0)
- +108 ;;=I69.953^^160^2124^35
- +109 ;;^UTILITY(U,$J,358.3,43551,1,0)
- +110 ;;=^358.31IA^4^2
- +111 ;;^UTILITY(U,$J,358.3,43551,1,3,0)
- +112 ;;=3^Hemiplegia Affecting Rt Non-Dominant Side
- +113 ;;^UTILITY(U,$J,358.3,43551,1,4,0)
- +114 ;;=4^I69.953
- +115 ;;^UTILITY(U,$J,358.3,43551,2)
- +116 ;;=^5007562
- +117 ;;^UTILITY(U,$J,358.3,43552,0)
- +118 ;;=I69.954^^160^2124^33